Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Transfusion ; 39(9): 948-50, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10533820

ABSTRACT

BACKGROUND: Anti-Tc(a) detects a high-incidence antigen in the Cromer blood group system. Cromer system antibodies have not usually been associated with hemolytic transfusion reactions or hemolytic disease of the newborn. CASE REPORT: Anti-Tc(a) (initially identified in the patient's serum in 1982) was not detected when she was admitted to the hospital with upper gastrointestinal. bleeding. Three units of red cells were administered. The patient was discharged, but was readmitted to the hospital after her hemoglobin fell to 7.1 g per dL. Antibody detection tests remained negative and three additional units were transfused. Over the next 7 days, her hemoglobin steadily fell to 5.5 g per dL. The level of lactate dehydrogenase rose to 1257, the plasma hemoglobin rose to >16 mg per dL, and the haptoglobin decreased to <6 mg per dL. Five days after transfusion, her direct antiglobulin test was weakly reactive with complement-specific antiglobulin reagents. Eluates were nonreactive. Anti-Tc(a) was detected in her serum; no other antibodies were detected. Differential typing failed to detect any circulating Tc(a+) red cells. The antibody was strongly reactive in a monocyte monolayer assay. CONCLUSION: Although Cromer system antibodies have generally not been proven to be clinically significant in transfusion therapy, the destruction of red cells from six units of transfused Tc(a+) red cells in this patient indicates that anti-Tc(a) may have destructive potential in some patients.


Subject(s)
Blood Group Antigens/immunology , Erythroblastosis, Fetal/etiology , Transfusion Reaction , Adult , Blood Grouping and Crossmatching , Coombs Test , Erythrocytes/immunology , Female , Humans , Infant, Newborn , Isoantibodies/adverse effects , Isoantibodies/blood , Pregnancy
2.
Clin Chem ; 33(8): 1484-5, 1987 Aug.
Article in English | MEDLINE | ID: mdl-3608181

ABSTRACT

A 50-year-old woman with metastatic rhabdomyosarcoma of the ovary had increased activities of creatine kinase (CK; EC 2.7.3.2), CK-MB isoenzyme, lactate dehydrogenase (LD; EC 1.1.1.27), and LD-2 isoenzyme in her serum. The isoenzyme activities did not show a pattern of increasing, then decreasing. Clinical findings, including electrocardiograms, did not support the diagnosis of myocardial infarction. We suggest that high activities of CK-MB and LD-2 in serum may serve as a marker of rhabdomyosarcoma.


Subject(s)
Creatine Kinase/blood , L-Lactate Dehydrogenase/blood , Ovarian Neoplasms/enzymology , Rhabdomyosarcoma/enzymology , Electrophoresis, Agar Gel , Female , Humans , Isoenzymes , Middle Aged , Myocardial Infarction/enzymology , Neoplasm Metastasis
SELECTION OF CITATIONS
SEARCH DETAIL
...